Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $1.365B (100.0% shares, 0.0% debt)

Holdings (31)

— MERUS N V 11.9%

Value $163M Shares 3,874,182 Est. Cost $28.41 Unrealized —

PCVX VAXCYTE INC 9.7%

Value $133M Shares 1,625,000 Est. Cost $73.44 Unrealized +35.2%

NUVL NUVALENT INC 9.3%

Value $127M Shares 1,621,600 Est. Cost $65.51 Unrealized +42.5%

XENE XENON PHARMACEUTICALS INC 7.9%

Value $107M Shares 2,740,000 Est. Cost $30.27 Unrealized +36.6%

ELVN ENLIVEN THERAPEUTICS INC 6.9%

Value $94.61M Shares 4,205,000 Est. Cost $18.81 Unrealized +37.8%

VERA VERA THERAPEUTICS INC 6.1%

Value $82.83M Shares 1,958,600 Est. Cost $8.35 Unrealized +430.2%

SLNO SOLENO THERAPEUTICS INC 5.0%

Value $68.55M Shares 1,525,000 Est. Cost $40.45 Unrealized +28.1%

ALKS ALKERMES PLC 4.8%

Value $66.15M Shares 2,300,000 Est. Cost $25.65 Unrealized +12.1%

NRIX NURIX THERAPEUTICS INC 4.1%

Value $56.52M Shares 3,000,000 Est. Cost $22.77 Unrealized +0.6%

COGT COGENT BIOSCIENCES INC 3.9%

Value $53.68M Shares 6,881,629 Est. Cost $8.23 Unrealized +21.1%

SYRE SPYRE THERAPEUTICS INC 3.4%

Value $46.28M Shares 1,988,084 Est. Cost $14.79 Unrealized +98.3%

VRDN VIRIDIAN THERAPEUTICS INC 3.4%

Value $46.01M Shares 2,400,000 Est. Cost $16.71 Unrealized +30.1%

SRRK SCHOLAR ROCK HLDG CORP 3.0%

Value $41.06M Shares 950,000 Est. Cost $32.56 Unrealized 0.0%

CNTA CENTESSA PHARMACEUTICALS PLC 2.7%

Value $37.16M Shares 2,218,425 Est. Cost $16.29 Unrealized —

PHVS PHARVARIS N V 2.7%

Value $36.64M Shares 1,911,433 Est. Cost $23.20 Unrealized -11.3%

— MIND MEDICINE MINDMED INC 2.2%

Value $29.99M Shares 4,308,425 Est. Cost $8.64 Unrealized —

ORKA ORUKA THERAPEUTICS INC 2.0%

Value $27.53M Shares 1,419,714 Est. Cost $34.43 Unrealized -29.1%

CRDF CARDIFF ONCOLOGY INC 1.7%

Value $23.37M Shares 5,384,616 Est. Cost $3.13 Unrealized 0.0%

IKT INHIBIKASE THERAPEUTICS INC 1.4%

Value $19.26M Shares 5,925,000 Est. Cost $2.49 Unrealized 0.0%

NGNE NEUROGENE INC 1.3%

Value $18.29M Shares 800,000 Est. Cost $36.26 Unrealized +2.6%

DRUG BRIGHT MINDS BIOSCIENCES INC 1.3%

Value $18.01M Shares 500,000 Est. Cost $35.19 Unrealized 0.0%

ORIC ORIC PHARMACEUTICALS INC 1.2%

Value $16.14M Shares 2,000,000 Est. Cost $11.88 Unrealized -22.7%

APGE APOGEE THERAPEUTICS INC 1.0%

Value $13.14M Shares 290,000 Est. Cost $25.01 Unrealized +103.9%

ABVX ABIVAX SA 0.7%

Value $9.4M Shares 1,284,110 Est. Cost $10.70 Unrealized —

PCSC PERCEPTIVE CAP SOLUTIONS COR 0.6%

Value $7.635M Shares 750,000 Est. Cost $10.07 Unrealized +0.3%

BBOT HELIX ACQUISITION CORP II 0.4%

Value $5.25M Shares 500,000 Est. Cost $10.35 Unrealized +1.5%

CELC CELCUITY INC 0.4%

Value $5.236M Shares 400,000 Est. Cost $18.21 Unrealized -22.5%

VTGN VISTAGEN THERAPEUTICS INC 0.3%

Value $4.646M Shares 1,575,000 Est. Cost $4.44 Unrealized -36.6%

AVTX AVALO THERAPEUTICS INC 0.3%

Value $3.589M Shares 483,000 Est. Cost $10.53 Unrealized +1.6%

— THIRD HARMONIC BIO INC 0.2%

Value $2.446M Shares 237,704 Est. Cost $12.09 Unrealized —

NKTX NKARTA INC 0.1%

Value $876K Shares 351,848 Est. Cost $4.61 Unrealized -33.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	3,874,182	$163M	11.9%	$28.41	—	COM	N5749R100
PCVX	VAXCYTE INC	1,625,000	$133M	9.7%	$73.44	+35.2%	COM	92243G108
NUVL	NUVALENT INC	1,621,600	$127M	9.3%	$65.51	+42.5%	COM	670703107
XENE	XENON PHARMACEUTICALS INC	2,740,000	$107M	7.9%	$30.27	+36.6%	COM	98420N105
ELVN	ENLIVEN THERAPEUTICS INC	4,205,000	$94.61M	6.9%	$18.81	+37.8%	COM	29337E102
VERA	VERA THERAPEUTICS INC	1,958,600	$82.83M	6.1%	$8.35	+430.2%	CL A	92337R101
SLNO	SOLENO THERAPEUTICS INC	1,525,000	$68.55M	5.0%	$40.45	+28.1%	COM	834203309
ALKS	ALKERMES PLC	2,300,000	$66.15M	4.8%	$25.65	+12.1%	SHS	G01767105
NRIX	NURIX THERAPEUTICS INC	3,000,000	$56.52M	4.1%	$22.77	+0.6%	COM	67080M103
COGT	COGENT BIOSCIENCES INC	6,881,629	$53.68M	3.9%	$8.23	+21.1%	COM	19240Q201
SYRE	SPYRE THERAPEUTICS INC	1,988,084	$46.28M	3.4%	$14.79	+98.3%	COM NEW	00773J202
VRDN	VIRIDIAN THERAPEUTICS INC	2,400,000	$46.01M	3.4%	$16.71	+30.1%	COM	92790C104
SRRK	SCHOLAR ROCK HLDG CORP	950,000	$41.06M	3.0%	$32.56	0.0%	COM	80706P103
CNTA	CENTESSA PHARMACEUTICALS PLC	2,218,425	$37.16M	2.7%	$16.29	—	SPONSORED ADS	152309100
PHVS	PHARVARIS N V	1,911,433	$36.64M	2.7%	$23.20	-11.3%	COM	N69605108
—	MIND MEDICINE MINDMED INC	4,308,425	$29.99M	2.2%	$8.64	—	COM NEW	60255C885
ORKA	ORUKA THERAPEUTICS INC	1,419,714	$27.53M	2.0%	$34.43	-29.1%	COM	687604108
CRDF	CARDIFF ONCOLOGY INC	5,384,616	$23.37M	1.7%	$3.13	0.0%	COM	14147L108
IKT	INHIBIKASE THERAPEUTICS INC	5,925,000	$19.26M	1.4%	$2.49	0.0%	COM NEW	45719W205
NGNE	NEUROGENE INC	800,000	$18.29M	1.3%	$36.26	+2.6%	COM	64135M105
DRUG	BRIGHT MINDS BIOSCIENCES INC	500,000	$18.01M	1.3%	$35.19	0.0%	COM NEW	10919W405
ORIC	ORIC PHARMACEUTICALS INC	2,000,000	$16.14M	1.2%	$11.88	-22.7%	COM	68622P109
APGE	APOGEE THERAPEUTICS INC	290,000	$13.14M	1.0%	$25.01	+103.9%	COM	03770N101
ABVX	ABIVAX SA	1,284,110	$9.4M	0.7%	$10.70	—	SPONSORED ADS	00370M103
PCSC	PERCEPTIVE CAP SOLUTIONS COR	750,000	$7.635M	0.6%	$10.07	+0.3%	CL A ORD SHS	G70077105
BBOT	HELIX ACQUISITION CORP II	500,000	$5.25M	0.4%	$10.35	+1.5%	CL A ORD SHS	G4444H101
CELC	CELCUITY INC	400,000	$5.236M	0.4%	$18.21	-22.5%	COM	15102K100
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$4.646M	0.3%	$4.44	-36.6%	COM	92840H400
AVTX	AVALO THERAPEUTICS INC	483,000	$3.589M	0.3%	$10.53	+1.6%	COM NEW	05338F306
—	THIRD HARMONIC BIO INC	237,704	$2.446M	0.2%	$12.09	—	COM	88427A107
NKTX	NKARTA INC	351,848	$876K	0.1%	$4.61	-33.0%	COM	65487U108